https://www.selleckchem.com/pr....oducts/hth-01-015.ht
Evidence suggests that neurometabolic abnormalities can persist after traumatic brain injury (TBI) and drive clinical symptoms such as fatigue and cognitive disruption. Magnetic resonance spectroscopy has been used to investigate metabolite abnormalities following TBI, but few studies have obtained data beyond the subacute stage or over large brain regions. To measure whole-brain metabolites in chronic stages of TBI. Observational study. University. Eleven men with a moderate or severe TBI more than 12 months prior and 10 age-matched
Like
Comment
Share
